Access Pharmaceuticals Inc, of Dallas, said Esteban Cvitkovic joined the board and assumed the title of vice chairman (Europe).
Acorda Therapeutics Inc., of Hawthorne, N.Y., elected Ian Smith to its board.
Acusphere Inc., of Watertown, Mass., hired Dennis Bucceri as senior vice president of regulatory affairs
Altea Therapeutics, of Atlanta, appointed William Good to its board.
Amylin Pharmaceuticals Inc., of San Diego, appointed Marcea Bland Lloyd as senior vice president, legal and corporate affairs, and general counsel.
Anthera Pharmaceuticals Inc., of San Mateo, Calif., hired David Waters as cardiovascular research fellow.
AtheroGenics Inc., of Atlanta, promoted Charles Deignan to vice president of finance and administration and principal accounting officer.
AtheroGenics Inc., of Atlanta, promoted Charles Kunsch to vice president, biology; James Sikorski to vice president, medicinal chemistry; and Cynthia Sundell to vice president, pharmacology.
Avigen Inc., of Alameda, Calif., said Stephen Dilly and Jan Ohrstrom were elected to its board.
Bioenvision Inc., of New York, said Yoshimaru Yamamoto joined Bioenvision JapanCo. Ltd. as a director and general manager.
Biotechnology Council of New Jersey, of Trenton, elected John Maki as a trustee.
Boston Life Sciences Inc., of Hopkinton, Mass., appointed Henry Brem and Gary Frashier to its board.
Cephalon Inc., of Frazer, Pa., promoted Mike Barr to vice president and general manager of Cephalon's Salt Lake City manufacturing, packaging and distribution facility. It also hired Lourdes Frau vice president, global product safety.
Chelsea Therapeutics International Ltd., of Charlotte, N.C., elected Kevan Clemens chairman.
Eurand, of Milan, Italy, appointed Manya Deehr chief legal officer and general counsel.
Exelixis Inc., of South San Francisco, appointed Carl Feldbaum to its board.
Isolagen Inc., of Exton, Pa., appointed Sandra Calman vice president and chief medical officer.
MediQuest Therapeutics Inc., of Bothell, Wash., hired Eric Batson as vice president of clinical development.
Medivir AB, of Huddinge, Sweden, appointed Borje Darpo vice president, pharmaceutical development.
MichBio, of Ann Arbor, Mich., elected former Congressman John Schwarz to its board.
NovaCardia Inc., of San Diego, appointed Joseph Turner to its board.
Response Biomedical Corp., of Vancouver, British Columbia, appointed Duane Morris chief operating officer. Also, Bill Radvak, president and CEO, intends to step down after a replacement is found.
Senomyx Inc., of San Diego, promoted Gwen Rosenberg to vice president, investor relations and corporate communications.
SensiGen LLC, of Ann Arbor, Mich., appointed George Smith III senior vice president for corporate development.
Sequenom Inc., of San Diego, named Steven Owings to the new position of vice president of commercial development, prenatal diagnostics.
Somaxon Pharmaceuticals Inc., of San Diego, appointed Robert Jones vice president, human resources, a new position.
Targanta Therapeutics, of Cambridge, Mass., appointed George Eldridge chief financial officer. It also appointed Paul Gesellchen vice president of regulatory affairs.
TetraLogic Pharmaceuticals Corp., of Malvern, Pa., said Andrew Pecora was added to its board.
ThromboGenics NV, of Leuven, Belgium, appointed Patrik De Haes chief operating officer and Franky Terras patent counsel.
ThromboVision Inc., of Houston, appointed Alan Jernigan vice president, worldwide sales and marketing, and Richard Thornton director of engineering and operations.
Tikvah Therapeutics Inc., of Atlanta, named Sandy Weinberg vice president of regulatory affairs and quality assurance.
VisEn Medical Inc., of Woburn, Mass., said Erik Wallden joined the company's board.
VioQuest Pharmaceuticals Inc., of Basking Ridge, N.J., appointed Edward Bradley chief scientific officer.
Vital Therapies Inc., of San Diego, appointed J. Michael Millis to its board.
Xanodyne Pharmaceuticals Inc., of Newport, Ky., appointed Rolf Classon chairman.
Xceed Molecular, of Wellesley, Mass., appointed David Deems president. Michael Cohen will assume the role of nonexecutive chairman.
Xencor Inc., of Monrovia, Calif., appointed Jade Brown vice president of business development.